Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications.
Cerebral expression of c-fos protein was studied by immunocytochemistry in murine cerebral malaria (CM) and malaria without cerebral involvement (non-CM). c-fos expression, low in the brains of uninfected mice, increased in frequency, intensity, and distribution during the course of fatal CM (e.g., a 70-fold increase on day 7 after inoculation). These changes paralleled the timing and degree of the neurologic complications and histopathologic changes. Only a slight increase in c-fos expression was detectable in non-CM mice on day 7 after inoculation. Dexamethasone treatment (days 0 and 1 after inoculation) of the CM mice largely prevented the increased cerebral c-fos expression, histopathologic changes, cerebral complications, and death. Increased c-fos expression may indicate the specific neuronal pathways activated by the immunopathologic process of fatal murine CM and could be associated with the behavioral changes and neurologic complications in this model.
Ma
N
N
Department of Pathology, University of Sydney, NSW, Australia.
Harding
A J
AJ
Pamphlett
R
R
Chaudhri
G
G
Hunt
N H
NH
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D001931:Brain Mapping; D002467:Cell Nucleus / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology; D004195:Disease Models, Animal; D005260:Female; D008288:Malaria / Q000378:metabolism; D016779:Malaria, Cerebral / Q000378:metabolism*; D051379:Mice; D008808:Mice, Inbred CBA; D009474:Neurons / Q000378:metabolism*; D010962:Plasmodium berghei; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis*
D000893:Anti-Inflammatory Agents; D016760:Proto-Oncogene Proteins c-fos; D003907:Dexamethasone